• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Word out of the Corporate Office...Heads To Roll...Starting with North East First









































“Why”???? You’re kidding, right?

Shares worth less than half, territory shrunk, tech offerings not way they were and this leadership team still has stumpy.

should I go on?
 












The boss hit the “sauce” one too many times.
Company had to toss the dross because he lost his gloss and failed to do more than floss.
Not much of a loss, since to remain is too high a cost.
Buh, Bye !!!
I am considering employment at Patterson Dental but i have heard from some folks that the new president is not delivering on his promises. Can someone shed dome light please?